Form 4: Twist Bioscience CFO Adam Laponis Sells Shares to Cover Tax Obligations

Adam Laponis, CFO of Twist Bioscience, sold 4,160 shares of common stock on November 6, 2024, to satisfy tax withholding obligations related to vesting Performance Stock Units.

Summary

• On November 6, 2024, Adam Laponis, the Chief Financial Officer of Twist Bioscience Corp, sold 4,160 shares of the company's common stock.
• The sale was executed at a price of $44.605 per share.
• This transaction was conducted to cover the reporting person's tax withholding obligations associated with the vesting of Performance Stock Units (PSUs).
• Following the transaction, Laponis directly owns 89,237 shares of Twist Bioscience Corp.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (selling shares to cover tax obligations), so the sentiment is neutral.

Industry Context

Sales of shares to cover tax obligations upon vesting of stock options or restricted stock units are a common practice among corporate executives.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact.

Key Dates